Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON34153
NL-OMON34153
Completed
Not Applicable

Faecal calprotectin as a diagnostic test for IBD in children in primary care - Calprotectin study

niversitair Medisch Centrum Groningen0 sites218 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCrohn's diseaseinflammatory bowel diseaseulcerative colitis10017969

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Crohn's disease
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
218
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Age 4\-18 years
  • •2\.Diarrhoea \>\= 2 weeks or \>\= 2 episodes of diarrhoea in the past 6 months or recurrent abdominal pain (\>\= 2 episodes of abdominal pain in the past 6 months)
  • •3\.Informed consent

Exclusion Criteria

  • •1\.Previously established diagnosis of chronic organic gastrointestinal disease
  • •2\.A complete evaluation in the past year for abdominal symptoms, including endoscopy
  • •3\.Chronic use of antibiotics, Non\-Steroidal Anti\-Inflammatory Drugs (NSAIDs) or oral corticosteroids.
  • •4\.Difficulty in understanding questionnaires due to cognitive impairment or language problems

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitis
NL-OMON25248KI-AV50
Unknown
Not Applicable
Usefulness of Calprotectin for Colon Adenoma ScreeningColon Adenoma
NCT01719198Konkuk University Medical Center500
Recruiting
Not Applicable
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot studycolitis10017966
NL-OMON42995ederlands Kanker Instituut50
Completed
Not Applicable
Value of Fecal CalprotectinCalprotectinInflammatory Bowel Disease
NCT00577928Indiana University171
Completed
Not Applicable
Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal TractPeptic EsophagitisPeptic UlcerFunctional DyspepsiaIrritable Bowel SyndromeInflammatory Bowel Diseases
NCT00920400University Hospital, Basel, Switzerland287